주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-03-28 16:29 (Thurs)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
41 )
기사목록 보기 형태
제목형
요약형
포토형
Korea's health insurance panel denies coverage for new cancer drugs
Kim Yun-mi
2024.03.07 15:38
All eyes of patients and drugmakers are on reimbursement of Enhertu
Kim Yun-mi
2024.03.06 11:39
Korea to launch MSD's 15-valent PCV vaccine in national immunization program
Kim Yun-mi
2024.03.05 11:37
Korean government stalls access to PARP inhibitors for prostate cancer patients
Kim Yun-mi
2024.02.28 13:24
Biliary tract cancer patients can now use Imfinzi at their own expense
Kim Yun-mi
2024.02.27 14:11
Balversa, 1st FGFR inhibitor for bladder cancer, will be available in Korea soon
Kim Yun-mi
2024.02.26 13:09
Jassen's delay in Korean launch of Balversa sparks speculation
Kim Yun-mi
2024.02.23 13:27
GSK's Shingrix vaccine linked to higher risk of ‘ophthalmic zoster’ recurrence: study
Kim Yun-mi
2024.02.20 13:24
After many twists and turns, Gilead's HIV drug Truvada survives in Korea
Kim Yun-mi
2024.02.19 14:51
New products stage sales war in ulcerative colitis treatment market
Kim Yun-mi
2024.02.15 11:21
BeiGene applies for insurance benefits for esophageal cancer drug Tevimbra
Kim Yun-mi
2024.02.13 13:12
Spravato faces crisis after back-to-back clinical trial failures in Japan and China
Kim Yun-mi
2024.02.06 11:31
처음
이전
이전
1
2
3
4
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기